相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression
Ya Bin Wei et al.
MOLECULAR PSYCHIATRY (2020)
Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future
Elina T. L'Estrade et al.
NEUROPHARMACOLOGY (2020)
A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs
Akane Yoshikawa et al.
PHARMACOGENOMICS JOURNAL (2020)
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
Stefan Leucht et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor
Kouji Fukuyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Evaluating lurasidone as a treatment option for bipolar disorder
Ziad Ali et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease
Marianna Crispino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action
Mei Huang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial
Eric J. Lenze et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
High Frequency of Undiagnosed Psychiatric Disorders in Inflammatory Bowel Diseases
Irene Marafini et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR
Umberto Restelli et al.
CLINICAL DRUG INVESTIGATION (2020)
Interaction between Mesocortical and Mesothalamic Catecholaminergic Transmissions Associated with NMDA Receptor in the Locus Coeruleus
Motohiro Okada et al.
BIOMOLECULES (2020)
Upregulated and Hyperactivated Thalamic Connexin 43 Plays Important Roles in Pathomechanisms of Cognitive Impairment and Seizure of Autosomal Dominant Sleep-Related Hypermotor Epilepsy with S284L-Mutant α4 Subunit of Nicotinic ACh Receptor
Kouji Fukuyama et al.
PHARMACEUTICALS (2020)
A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Upregulated Connexin 43 Induced by Loss-of-Functional S284L-Mutant α4 Subunit of Nicotinic ACh Receptor Contributes to Pathomechanisms of Autosomal Dominant Sleep-Related Hypermotor Epilepsy
Kouji Fukuyama et al.
PHARMACEUTICALS (2020)
Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia
Herbert Y. Meltzer et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2020)
Pharmacology and Therapeutic Potential of the 5-HT7 Receptor
Kevin M. Blattner et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex
Motohiro Okada et al.
NEUROPHARMACOLOGY (2019)
Lurasidone inhibits NMDA receptor antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-HT7 receptor blockade
Motohiro Okada et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone
Filippo Corponi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
Eduard Vieta et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2019)
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
Maximilian Huhn et al.
LANCET (2019)
Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor
Kouji Fukuyama et al.
BIOMOLECULES (2019)
Thalamocortical Circuit Motifs: A General Framework
Michael M. Halassa et al.
NEURON (2019)
The blockade of the serotoninergic receptors 5-HT5A, 5-HT6 and 5-HT7 in the basolateral amygdala, but not in the hippocampus facilitate the extinction of fear memory
Eduardo Silva de Assis Brasil et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical Transmissions
Motohiro Okada et al.
BIOMOLECULES (2019)
Psychosis in neurodegenerative disorders: recent developments
Wael K. Karameh et al.
CURRENT OPINION IN PSYCHIATRY (2019)
Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT1A Receptor with 5-HT3 Receptor Inhibition in Rats
Motohiro Okada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc-
Motohiro Okada et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus
Motohiro Okada et al.
PHARMACEUTICALS (2019)
Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis
Michael Ostacher et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2018)
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines
N. Verdolini et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
The Mediodorsal Thalamus: An Essential Partner of the Prefrontal Cortex for Cognition
Sebastien Parnaudeau et al.
BIOLOGICAL PSYCHIATRY (2018)
Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma
Ilhan Elmaci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Input Convergence, Synaptic Plasticity and Functional Coupling Across Hippocampal-Prefrontal-Thalamic Circuits
Lezio S. Bueno-Junior et al.
FRONTIERS IN NEURAL CIRCUITS (2018)
Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites
Kouji Fukuyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Serotonin receptors in depression and anxiety: Insights from animal studies
Elzbieta Zmudzka et al.
LIFE SCIENCES (2018)
Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission
Kouji Fukuyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome
Lara Costa et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
In Hee Shim et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2018)
Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro
Beyzagul Polat et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Replication of rs300774, a genetic biomarker near ACP1, associated with suicide attempts in patients with schizophrenia: Relation to brain cholesterol biosynthesis
Jiang Li et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study
Melissa P. DelBello et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2017)
Osteopontin inhibits osteoblast responsiveness through the down-regulation of focal adhesion kinase mediated by the induction of low-molecular weight protein tyrosine phosphatase
Joji Kusuyama et al.
MOLECULAR BIOLOGY OF THE CELL (2017)
Modulation of the consolidation and reconsolidation of fear memory by three different serotonin receptors in hippocampus
S. D. Schmidt et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2017)
CaMKII Autophosphorylation Is Necessary for Optimal Integration of Ca2+ Signals during LTP Induction, but Not Maintenance
Jui-Yun Chang et al.
NEURON (2017)
TOWARD A THEORETICAL ROLE FOR TONIC NOREPINEPHRINE IN THE ORBITOFRONTAL CORTEX IN FACILITATING FLEXIBLE LEARNING
Brian F. Sadacca et al.
NEUROSCIENCE (2017)
Neurochemical arguments for the use of dopamine D4 receptor stimulation to improve cognitive impairment associated with schizophrenia
Mei Huang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial
John Sramek et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
How serotonin receptors regulate morphogenic signalling in neurons
Alexander Wirth et al.
PROGRESS IN NEUROBIOLOGY (2017)
Synaptic Remodeling Depends on Signaling between Serotonin Receptors and the Extracellular Matrix
Monika Bijata et al.
CELL REPORTS (2017)
Placebo Response and Practice Effects in Schizophrenia Cognition Trials
Richard S. E. Keefe et al.
JAMA PSYCHIATRY (2017)
New Trends in the Treatment of Schizophrenia
Herbert Y. Meltzer
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
Diverse Effects of Gut-Derived Serotonin in Intestinal Inflammation
Md. Sharif Shajib et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis
Alan C. Swann et al.
CNS SPECTRUMS (2017)
Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study
Joyce Tsai et al.
CNS SPECTRUMS (2017)
Deletion of the serotonin receptor type 7 disrupts the acquisition of allocentric but not egocentric navigation strategies in mice
Gregory Beaudet et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis
Yoshiteru Takekita et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
Rajiv Tandon et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice
Lakshmi Rajagopal et al.
PSYCHOPHARMACOLOGY (2016)
Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study
Trisha Suppes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo
Filippo Andreetta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomnia
Andrew D. Krystal et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2016)
Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies
Martha Sajatovic et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Effects of 5-HT-7 receptor ligands on memory and cognition
Nicholas Zareifopoulos et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2016)
The 5-HT7 receptor triggers cerebellar long-term synaptic depression via PKC-MAPK
Pellegrino Lippiello et al.
NEUROPHARMACOLOGY (2016)
Morphological Alterations in the Thalamus, Striatum, and Pallidum in Autism Spectrum Disorder
Manuela Schuetze et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Interventions for tic disorders: An overview of systematic reviews and meta analyses
Chunsong Yang et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review
Vera De Carlo et al.
PSYCHIATRY RESEARCH (2016)
Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors
Malgorzata Holuj et al.
BEHAVIOURAL PHARMACOLOGY (2015)
The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors
K. W. Andressen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cessation of gamma activity in the dorsomedial nucleus associated with loss of consciousness during focal seizures
B. A. Leeman-Markowski et al.
EPILEPSY & BEHAVIOR (2015)
Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial
Roger S. McIntyre et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Spinal 5-HT7 receptors induce phrenic motor facilitation via EPAC-mTORC1 signaling
D. P. Fields et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients
Yoshiteru Takekita et al.
NEUROPSYCHOBIOLOGY (2015)
Limbic circuitry of the midline thalamus
Robert P. Vertes et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Effect of lurasidone dose on cognition in patients with schizophrenia: Post-hoc analysis of a long-term, double-blind continuation study
Philip D. Harvey et al.
SCHIZOPHRENIA RESEARCH (2015)
Stimulation of 5-HT7 Receptor During Adolescence Determines its Persistent Upregulation in Adult Rat Forebrain Areas
Paola Nativio et al.
SYNAPSE (2015)
5-HT7 receptor modulates GABAergic transmission in the rat dorsal raphe nucleus and controls cortical release of serotonin
Magdalena Kusek et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics
Luisa Speranza et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Spatial memory deficit across aging: current insights of the role of 5-HT7 receptors
Gregory Beaudet et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression
Krithika Rajagopalan et al.
JOURNAL OF MEDICAL ECONOMICS (2015)
Epac activation initiates associative odor preference memories in the rat pup
Matthew T. Grimes et al.
LEARNING & MEMORY (2015)
Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Antony Loebel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Antony Loebel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Neuronal Plasticity: Beyond the Critical Period
Mark Huebener et al.
CELL (2014)
D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder
Steven G. Potkin et al.
CNS SPECTRUMS (2014)
Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
Leslie Citrome et al.
CNS SPECTRUMS (2014)
Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT) 2A and DA D2 antagonism and 5-HT1A partial agonism
Mei Huang et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway
Kouji Fukuyama et al.
NEUROPHARMACOLOGY (2014)
A STEREOLOGICAL STUDY OF THE MEDIODORSAL THALAMIC NUCLEUS IN DOWN SYNDROME
A. S. Karlsen et al.
NEUROSCIENCE (2014)
The serotonin receptor 7 and the structural plasticity of brain circuits
Floriana Volpicelli et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
CURRENT PHARMACOTHERAPEUTIC APPROACHES FOR THE TREATMENT OF TOURETTE SYNDROME
A. Egolf et al.
DRUGS OF TODAY (2014)
A Head-to-Head Comparison of Aripiprazole and Risperidone for Safety and Treating Autistic Disorders, a Randomized Double Blind Clinical Trial
Ahmad Ghanizadeh et al.
CHILD PSYCHIATRY & HUMAN DEVELOPMENT (2014)
Structural plasticity of dendritic spines: The underlying mechanisms and its dysregulation in brain disorders
Kwok-On Lai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
ONO-2506 inhibits spikewave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation
Satoshi Yamamura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension
Philip D. Harvey et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia
Herbert Y. Meltzer et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study
Stephen M. Stahl et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal Inflammation
Janice J. Kim et al.
JOURNAL OF IMMUNOLOGY (2013)
Electrophysiological and pharmacological properties of GABAergic cells in the dorsal raphe nucleus
Yoshihiro Gocho et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2013)
Brain Region-Specific Transcriptomic Markers of Serotonin-1A Receptor Agonist Action Mediating Sexual Rejection and Aggression in Female Marmoset Monkeys
Yves Aubert et al.
JOURNAL OF SEXUAL MEDICINE (2013)
The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways
L. Speranza et al.
NEUROPHARMACOLOGY (2013)
Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats
Arne Mork et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Evaluation of dopamine D-2/D-3 and serotonin 5-HT2A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography
Shunsuke Nakazawa et al.
PSYCHOPHARMACOLOGY (2013)
Determination of dopamine D2 receptor occupancy by lurasidone using positron emission tomography in healthy male subjects
Dean F. Wong et al.
PSYCHOPHARMACOLOGY (2013)
Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study
Antony Loebel et al.
SCHIZOPHRENIA RESEARCH (2013)
Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial-mesenchymal transition of cancer cells
C. R. I. Lam et al.
CELL DEATH & DISEASE (2013)
Profile of blonanserin for the treatment of schizophrenia
Tomomi Tenjin et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2013)
Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons
Maryam S. Vasefi et al.
MOLECULAR BRAIN (2013)
The serotonin 5-HT7 receptors: two decades of research
Evelien Gellynck et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
Annual cost of relapses and relapse-related hospitalizations in adults with schizophrenia: results from a 12-month, double-blind, comparative study of lurasidone vs quetiapine extended-release
Krithika Rajagopalan et al.
JOURNAL OF MEDICAL ECONOMICS (2013)
Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood Disorders
Francisco López-Muñoz et al.
Frontiers in Psychiatry (2013)
Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome
Lara Costa et al.
BIOLOGICAL PSYCHIATRY (2012)
Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
Shunske Tanahashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Structural plasticity of dendritic spines
Miguel Bosch et al.
CURRENT OPINION IN NEUROBIOLOGY (2012)
5-HT1A and 5-HT7 receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission
L. Costa et al.
HIPPOCAMPUS (2012)
Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study
Leslie Citrome et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking
Ute Renner et al.
JOURNAL OF CELL SCIENCE (2012)
5-HT7R/G12 Signaling Regulates Neuronal Morphology and Function in an Age-Dependent Manner
Fritz Kobe et al.
JOURNAL OF NEUROSCIENCE (2012)
Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission
Shunsuke Tanahashi et al.
NEUROPHARMACOLOGY (2012)
5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: Implications for effects of selective serotonin reuptake inhibitors
Therese M. Eriksson et al.
NEUROPHARMACOLOGY (2012)
Translational Evaluation of JNJ-18038683, a 5-Hydroxytryptamine Type 7 Receptor Antagonist, on Rapid Eye Movement Sleep and in Major Depressive Disorder
Pascal Bonaventure et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Sensory Pathways and Emotional Context for Action in Primate Prefrontal Cortex
Helen Barbas et al.
BIOLOGICAL PSYCHIATRY (2011)
The role of serotonin receptors in the action of atypical antipsychotic drugs
H. Y. Meltzer et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment
Veit Roessner et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2011)
Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex
Keiko Ohoyama et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
Benny Bang-Andersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats
M. Horiguchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives
Anne Matthys et al.
MOLECULAR NEUROBIOLOGY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions
Satoshi Yamamura et al.
NEUROPHARMACOLOGY (2011)
Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
Ouissame Mnie-Filali et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
Steven G. Potkin et al.
SCHIZOPHRENIA RESEARCH (2011)
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone
Philip D. Harvey et al.
SCHIZOPHRENIA RESEARCH (2011)
Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines
R. E. Kast
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target
Erik D. Wiklund et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
Tadashi Ishibashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The 5-HT7 receptor is involved in allocentric spatial memory information processing
Gor Sarkisyan et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex
S. Yamamura et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology
D. Leo et al.
GENES BRAIN AND BEHAVIOR (2009)
What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
Bradley N. Gaynes et al.
PSYCHIATRIC SERVICES (2009)
Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved
Arne Mork et al.
PSYCHOPHARMACOLOGY (2009)
Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex
Satoshi Yamamura et al.
PSYCHOPHARMACOLOGY (2009)
5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT1A receptor stimulation on contextual learning in mice
Therese M. Eriksson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice
Mark S. Ansorge et al.
JOURNAL OF NEUROSCIENCE (2008)
Rapid synaptic scaling induced by changes in postsynaptic firing
Keiji Ibata et al.
NEURON (2008)
Synaptic plasticity: Multiple forms, functions, and mechanisms
Ami Citri et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Neurotoxic lesions of the medial mediodorsal nucleus of the thalamus disrupt reinforcer devaluation effects in rhesus monkeys
Anna S. Mitchell et al.
JOURNAL OF NEUROSCIENCE (2007)
Morphogenic signaling in neurons via neurotransmitter receptors and small GTPases
Evgeni Ponimaskin et al.
MOLECULAR NEUROBIOLOGY (2007)
Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents
Pascal Bonaventure et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder
Peter B. Hedlund et al.
NEUROSCIENCE LETTERS (2007)
Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats
Anna Wesolowska et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Cortical serotonin7, 1D and 1F receptors:: Effects of schizophrenia, suicide and antipsychotic drug treatment
Brian Dean et al.
SCHIZOPHRENIA RESEARCH (2006)
Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor
Carol Smith et al.
MOLECULAR PHARMACOLOGY (2006)
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine
S Bender et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population
M Ikeda et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression
Anna Wesolowska et al.
NEUROPHARMACOLOGY (2006)
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
PB Hedlund et al.
BIOLOGICAL PSYCHIATRY (2005)
Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex
A Zocchi et al.
NEUROSCIENCE LETTERS (2005)
5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology
E Kvachnina et al.
JOURNAL OF NEUROSCIENCE (2005)
Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms
CR Guthrie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents
J Fernández et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression
M Guscott et al.
NEUROPHARMACOLOGY (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Mice lacking 5-HT7 receptors show specific impairments in contextual learning
AJ Roberts et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone
D Mamo et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons
K Tokarski et al.
BRAIN RESEARCH (2003)
Serotonin receptors : their key role in drugs to treat schizophrenia
HY Meltzer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Coupling of neuronal 5-HT7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac
SL Lin et al.
JOURNAL OF NEUROCHEMISTRY (2003)
An RT-PCR study of 5-HT6 and 5-HT7 receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia
SZ East et al.
SCHIZOPHRENIA RESEARCH (2002)
Differential modulation of Ih by 5-HT receptors in mouse CA1 hippocampal neurons
U Bickmeyer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus
JLW Yau et al.
NEUROSCIENCE LETTERS (2001)
The cloned human 5-HT7 receptor splice variants:: a comparative characterization of their pharmacology, function and distribution
KA Krobert et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2001)
Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?:: A new hypothesis
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
分享论文
